Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Kakkis Emil D
Relationship:  
City:   Novato
State:   CA
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   603,534    

Indirect Shares

   2,268,639      
Direct Value   $26,857,607    

Indirect Value

   $94,141,463      
Total Shares   2,872,173      
Total Value   $120,999,070      


Biomarin Pharmaceutical Inc $3,511,609 Ultragenyx Pharmaceutical Inc $23,345,998 Biomarin Pharmaceutical Inc $3,511,609 Ultragenyx Pharmaceutical Inc $23,345,998
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Chief Medical Officer 2009-03-02 39,621 2009-03-02 4,654    Premium*  
            Ultragenyx Pharmaceutical Inc RARE 2024-03-01 563,913 2024-03-01 2,263,985    Premium*  
* Premium Members only  

Records found :    106         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2016-10-14 4 AS $61.97 $1,260,360 D/D (20,000) 467,147 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2016-11-15 4 AS $79.39 $1,625,753 D/D (20,000) 447,147 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2016-12-22 5 GD $0.00 $0 D/D 27,500 419,647 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2017-03-01 4 A $0.00 $0 D/D 13,000 432,647 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2017-05-21 4 D $57.47 $61,608 D/D (1,072) 431,575 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2017-06-01 4 D $56.61 $56,950 D/D (1,006) 430,569 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2017-08-28 4 B $52.40 $393,922 I/I 7,500 2,559,741 2.66 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2018-03-01 4 D $48.43 $53,951 D/D (1,114) 448,955 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2018-03-01 4 A $0.00 $0 D/D 19,500 450,069 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2018-04-19 4 A $0.00 $0 D/D 3,429 452,384 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2018-05-21 4 D $64.79 $63,883 D/D (986) 451,398 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2018-06-01 4 D $73.73 $68,274 D/D (926) 450,472 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2019-03-01 4/A A $0.00 $0 D/D 20,000 470,473 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2019-03-01 4 D $67.55 $189,275 D/D (2,802) 467,670 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2019-03-01 4 A $0.00 $0 D/D 20,000 470,472 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2019-03-05 4/A S $65.52 $189,353 D/D (2,890) 467,583 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2019-04-19 4 D $64.43 $51,415 D/D (798) 466,785 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2019-05-06 4 A $0.00 $0 D/D 3,435 470,220 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2019-05-21 4 D $59.50 $84,133 D/D (1,414) 468,806 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2019-06-01 4 D $54.93 $72,892 D/D (1,327) 467,479 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2019-09-11 4 B $43.63 $218,150 D/D 5,000 472,479 2.81 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2019-10-14 4 A $0.00 $0 D/D 3,435 475,914 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2020-03-01 4 A $0.00 $0 D/D 35,782 511,696 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2020-03-01 4 D $56.08 $386,728 D/D (6,896) 504,800 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2020-03-12 4 OE $3.01 $449,998 D/D 149,700 654,500 0 -
  106  Records found
  1   2   3  4   5      
  Page 3 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us